Skip to content

Determination of Risk Factors of Ventricular Arrhythmias (VAs) After Implantation of Continuous Flow Left Ventricular Assist Device With Continuous Flow Left Ventricular Assist Device (CF-LVAD)

Interest of Implantable Cardioverter-defibrillator in Primary Prevention in Patient With Continuous Flow Left Ventricular Assist Device (CF-LVAD)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02873169
Acronym
ASSIST-ICD
Enrollment
681
Registered
2016-08-19
Start date
2015-09-30
Completion date
2016-12-31
Last updated
2017-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Cardiac Insufficiency

Keywords

Left ventricular assist device, Ventricular Arrhythmias, Implantable Cardioverter-defibrillator

Brief summary

Determination of risk factors of ventricular arrhythmias (VAs) after implantation of continuous flow left ventricular assist device in order to characterize which patient requires ICD implantation in primary prevention.

Interventions

Collection of clinical, biological, hemodynamic and rhythmic data

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient above 18 years old * Patients with CF-LVAD with or without ICD

Exclusion criteria

* Patients subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of early VAs (<30 days post operatively) and late VAs (>30 days post operatively) in patient with CF-LVAD with or without ICD30 daysClinical, biological, hemodynamic and rhythmic data

Secondary

MeasureTime frame
Mortality in patients with CF-LVAD with or without VAs30 days
Mortality in patients with CF-LVAD with or without ICD30 days

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026